Discuss the significance of the National Research Foundation in reforming India's research funding architecture. What challenges remain in achieving India's GERD target of 2% of GDP by 2035?

India's Gross Expenditure on R&D (GERD) stood at just 0.64% of GDP in 2020-21, against the 2% goal set since the 2013 STI Policy [3]. The Anusandhan National Research Foundation (ANRF), 2023 is the most significant institutional attempt yet to fix the financing architecture behind this gap.

Significance of ANRF for research funding

• Single apex funder: it repeals the Science and Engineering Research Board Act, 2008 and subsumes SERB, replacing scattered schemes with one strategic funding body [2].
• Scale of resources: an outlay of ₹50,000 crore for 2023-28, of which ₹14,000 crore is budgetary and ₹36,000 crore is to come from industry, philanthropy and international sources [1].
• Crowding in private capital: directly targets India's skewed 64:36 government-to-private funding split, the inverse of developed economies [3].
• Democratising research: dedicated competitive windows for state universities and colleges, moving funding beyond IITs and central institutes [1].
• High-level direction: a Prime Minister-chaired Governing Board and an Executive Council under the Principal Scientific Adviser link research funding to national priorities [2].

Challenges to reaching 2% by 2035

• Base effect: tripling R&D intensity from 0.64% while GDP itself grows demands a sustained real increase far beyond current budget trends [3].
• Uncertain private response: business R&D has stagnated at about 0.25% of GDP; the ₹36,000 crore non-government share remains an aspiration, not a commitment [3][1].
• Human capital deficit: only 262 researchers per million population, against 8,714 in South Korea and 8,342 in Israel — money cannot be absorbed without people [4].
• Persistent fragmentation: large streams under CSIR, ICMR, DBT, DRDO and ISRO lie outside ANRF, and states contribute marginally.
• Delivery capacity: transparent peer review, timely disbursal and institutional autonomy remain untested.

ANRF thus reforms the architecture of research funding, but the quantum depends on sustained public commitment and a genuine industry response. Predictable multi-year allocations, tax and procurement incentives for corporate R&D, and expansion of doctoral capacity can convert the 2% target into an achievable trajectory — advancing the constitutional duty under Article 51A(h) to develop the scientific temper.